Sanofi SA (SNY)
49.46
-0.57
(-1.14%)
USD |
NASDAQ |
May 02, 16:00
49.44
-0.02
(-0.04%)
After-Hours: 20:00
Sanofi Max Drawdown (5Y): 33.52% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 33.52% |
March 31, 2024 | 33.52% |
February 29, 2024 | 33.52% |
January 31, 2024 | 33.52% |
December 31, 2023 | 33.52% |
November 30, 2023 | 33.52% |
October 31, 2023 | 33.52% |
September 30, 2023 | 33.52% |
August 31, 2023 | 33.52% |
July 31, 2023 | 33.52% |
June 30, 2023 | 33.52% |
May 31, 2023 | 33.52% |
April 30, 2023 | 33.52% |
March 31, 2023 | 33.52% |
February 28, 2023 | 33.52% |
January 31, 2023 | 33.52% |
December 31, 2022 | 33.52% |
November 30, 2022 | 33.52% |
October 31, 2022 | 33.52% |
September 30, 2022 | 33.52% |
August 31, 2022 | 27.68% |
July 31, 2022 | 26.40% |
June 30, 2022 | 26.40% |
May 31, 2022 | 26.40% |
April 30, 2022 | 26.40% |
Date | Value |
---|---|
March 31, 2022 | 26.40% |
February 28, 2022 | 26.40% |
January 31, 2022 | 26.40% |
December 31, 2021 | 26.40% |
November 30, 2021 | 26.40% |
October 31, 2021 | 26.40% |
September 30, 2021 | 27.58% |
August 31, 2021 | 27.58% |
July 31, 2021 | 30.36% |
June 30, 2021 | 30.36% |
May 31, 2021 | 30.36% |
April 30, 2021 | 30.36% |
March 31, 2021 | 30.36% |
February 28, 2021 | 30.36% |
January 31, 2021 | 30.36% |
December 31, 2020 | 30.36% |
November 30, 2020 | 30.85% |
October 31, 2020 | 30.85% |
September 30, 2020 | 30.85% |
August 31, 2020 | 30.85% |
July 31, 2020 | 30.85% |
June 30, 2020 | 30.85% |
May 31, 2020 | 30.85% |
April 30, 2020 | 30.85% |
March 31, 2020 | 30.85% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
26.40%
Minimum
Oct 2021
33.52%
Maximum
Sep 2022
30.77%
Average
30.85%
Median
May 2019
Max Drawdown (5Y) Benchmarks
AstraZeneca PLC | 24.93% |
GSK PLC | 50.14% |
Novo Nordisk A/S | 23.65% |
Regeneron Pharmaceuticals Inc | 53.84% |
Biophytis SA | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -2.457 |
Beta (5Y) | 0.6065 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 22.97% |
Historical Sharpe Ratio (5Y) | 0.1872 |
Historical Sortino (5Y) | 0.2677 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.43% |